A clinical study of MK-3475A to treat newly-diagnosed metastatic non-small cell lung cancer (MK-3475A-F84)

Trial Identifier: 3475A-F84
Sponsor: MSD
Start Date: November 2024
Primary Completion Date: June 2026
Study Completion Date: February 2030
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary - English

Trial Locations

Country Location
Korea, Republic of, Pusan-Kwangyokshi Pusan Kwangyokshi, Pusan-Kwangyokshi, Korea, Republic of, 49241
Korea, Republic of, Seoul Seoul, Korea, Republic of, 8308
Korea, Republic of, Taejon-Kwangyokshi Daejeon, Taejon-Kwangyokshi, Korea, Republic of, 35015
Poland, Mazowieckie Siedlce, Mazowieckie, Poland, 08-110
Romania, Cluj Cluj, Romania, 400015
Romania, Cluj Floresti, Cluj, Romania, 407280
Spain, Huelva Huelva, Spain, 21005